<- Go Home

LifeMD, Inc.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Market Cap

$331.8M

Volume

749.3K

Cash and Equivalents

$37.6M

EBITDA

-$18.0M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$173.1M

Profit Margin

89.64%

52 Week High

$12.88

52 Week Low

$3.99

Dividend

N/A

Price / Book Value

-41.48

Price / Earnings

-11.80

Price / Tangible Book Value

-13.65

Enterprise Value

$321.1M

Enterprise Value / EBITDA

-18.88

Operating Income

-$19.3M

Return on Equity

260.40%

Return on Assets

-21.34

Cash and Short Term Investments

$37.6M

Debt

$25.1M

Equity

-$6.0M

Revenue

$193.1M

Unlevered FCF

$18.4M

Sector

Health Care Technology

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches